Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Investigational new drugs 2008-02, Vol.26 (1), p.95-96
Hauptverfasser:	Asmis, Timothy R., Chung, Ki Y., Teitcher, Jerrold B., Kelsen, David P., Shah, Manish A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - adverse effects Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Asymptomatic Bevacizumab Blood vessels Cancer therapies Carcinoma, Neuroendocrine - drug therapy Carcinoma, Neuroendocrine - secondary Chemotherapy Colorectal cancer Constipation Gastrointestinal diseases Humans Hypotheses Male Medical imaging Medicine Medicine & Public Health Metastasis Middle Aged Oncology Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - pathology Patients Pharmacology/Toxicology Pneumatosis Cystoides Intestinalis - chemically induced Pneumatosis Cystoides Intestinalis - diagnosis Sepsis Short Report Tomography Toxicity Vascular Endothelial Growth Factor A - antagonists & inhibitors Vascular Endothelial Growth Factor A - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!